Szemészet, 2021 (158. évfolyam, 1-4. szám)

2021-09-01 / 3. szám

The changing practice of screening for diabetic retinopathy

6. Diabetic

retinopathy screening: a short guide. Copenhagen: WHO Regional Office for Europe: 2020.

7. Early

Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch Ophthalmol 1995:113:1144-55. https://doi.org/10.1001/archopht.1995.01100090070025

8. Fiedler

0, Hargitai

Zs,

Bíró

Zs,

Ölvedy

V,

Szabó

D,

Pregun I, Pusztai

P,

Somogyi A,

Németh J.

Diabéteszes

retinopathia

telemedicinális

szűrése: pilot study. Magyar

Belorvosi Archívum 2010: 63: 81-86.

9. Genuth

S, Eastman R, Kahn

R,

Klein R, Lachin

J, Lebovitz

H, Nathan

D,

Vinicor F. Implications

of the United

Kingdom

prospective diabetes study. Diabetes Care 2003; 26: S28-32.

https://doi.org/10.2337/diacare.26.2007.s28

10. Huemer

J, Wagner SK, Sim DA. The Evolution of Diabetic Retinopathy Screening Programmes: A Chronology of Retinal Photography from 35 mm Slides to Artificial Intelligence. ClinOphthalmol 2020; 14: 2021-2035. https://doi.org/10.2147/OPTH.S261629

11. International

Council of Ophthalmology Guidelines for Diabetic EyeCare 2017

12. Invernizzi

A,

Bevilacqua MT, Cozzi

M,

Bianchi C, Pagani A, Cigada M, Staurenghi G. Diabetic retinopathy screening: the first telemedical approach in an Italian hospital. Eur J Ophthalmol 2016; 26: 369-74.

https://doi.org/10.5301/ejo.5000719.

13. Kiss

H, Németh

J.

A

vakság okai Magyarországon. Szemészet 2013; 150:103-110.

14. Klein

R, Klein BE, Moss SE, Davis MD, DeMets DL. The

Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527-32. https://doi.org/10.1001/archopht.1984.01040030405011

15. Klein

R, Klein BE. Are individuals with diabetes seeing better? a longterm epidemiological perspective. Diabetes 2010; 59: 1853-60.

https://doi.org/10.2337/db09-1904

16. Kumar

S, Wang EH, Pokabla MJ, Noecker

RJ.

Teleophthalmology assessment of diabetic retinopathy fundus images: smartphone versus standard office computer workstation. Telemed J E Health 2012; 18: 158-62. https://doi.org/10.1089/tmj.2011.0089

17. Kuper

H, Polack

S,

Limburg H. Rapid assessment of avoidable blindness. Community Eye Health 2006; 19: 68-69.

18. Lam

DW, LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes 2012; 19: 93-96.

https://doi.org/10.1097/MED.0b013e328350583a

19. Lee

PP, Feldman ZW, Ostermann

J,

Brown OS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology 2003; 110: 1952-9.

https://doi.org/10.1016/S0161-6420(03)00817-0

20. Lind

M, Pivodic A, Svensson A,

Ólafsdóttir AF,

Wedel H, Ludvigsson J. HbA,c levelas a riskfactor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study. BMJ 2019; 366: I4894. https://doi.org/10.1136/bmj.l4894

21. Lodhia

V, Karanja S. Acceptability, Usability, and View son Deployment of Peek, a Mobile Phonem

Health

Intervention for Eye Carein Kenya: Qualitative Study. JMIR Mhealth Uhealth 2016; 4: e30.

https://doi.org/1O.2196/mhealth.4746

22. M.

Kir. Központi

Statisztikai Hivatal. A magyar szent korona országaiban az 1912. évben végrehajtott vakságügyi statisztika eredményei. In: Központi Statisztikai Hivatal (szerk.), Magyar Statisztikai Közlemények. Új sorozat. 55. kötet, Budapest: Pesti Nyomda; 1916.

23. Massin

P,

Chabouis A, Erginay A, Viens-Bitker C, Lecleire-Collet A, Meas T,

Guillausseau PJ, Choupot G, Andre

B,

Denormandie

P.

OPHDIAT: a telemedical network screening system for diabetic retinopathy in the lle-de France. Diabetes Metab 2008; 34: 227-34. https://doi.Org/10.1016/j.diabet.2007.12.006

24. Micheletti

JM, Hendrick AM, Khan FN, Ziemer

DC,

Pasquel FJ. Current and Next Generation Portable Screening Devices for Diabetic Retinopathy. J Diabetes Sei

Technoi

2D16;

10: 295-300.

https://doi.org/10.1177/1932296816629158

25. Németh

J,

Frigyik

A, Vastag 0,

Göcze

P, Pető

T. Vaksági okok Magyarországon 1996 és 2000 között. Szemészet 2005; 142:126-132.

26. Németh

J, Süveges I. Vision 2020 - Világméretű program az elkerülhető vakság felszámolására. Szerkesztőségi közlemény a Látás napja alkalmából. Szemészet 2001; 138: 115-117.

27. Németh

J, Szabó D, Tóth G, Sándor GL, Lukács R, Pék A, Szalai

I,

Papp

A, Resnikoff S, Limburg H. Feasibility of the rapid assessment of avoidable blindness with diabetic retinopathy module (RAAB+DR) in industrialised countries: challenges and lessons learned in Hungary. Ophthalmic Epidemiol 2018; 25: 273-279. 28. Németh

J,

Váry

I,

Betkó

J,

Hatvani

I.

Magyar Szemészeti

Bibliográfia. Budapest: Nyctalus Orvosi

Kiadó; 2006.

p.

40-42.

https://doi.Org/10.1080/09286586.2018.1438634

29. Németh

J. Működő telemedicinális szemészeti szűrőprogramok és lehetőségek hazánkban. ÍME 2019; 8: 46-51.

30. Nordwall

M,

Bojestig

M, Arnqvist HJ, Ludvigsson J.

Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linkoping Diabetes Complications Study. Diabetologia 2004; 47: 1266-1272.

https://doi.org/1O.1OO7/sOO125-OO4-1431-6

31. Norgaard

MF, Grauslund J. Automated Screening for Diabetic Retinopathy-A Systematic Review. Ophthalmic Res 2018; 60: 9-17.

https://doi.org/10.1159/000486284

32. Ogurtsova

K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw

JE, Makaroff

LE. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50. 33. Pambianco

G,

Costacou

T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006;

https://doi.Org/1O.1O16/j.diabres.2O17.O3.O24

55: 1463-9.

.https://doi.org/1O.2337/dbO5-1423

34. Papp

A.

A diabetészes maculaödéma korszerű kezelése. Szemészet 2016; 153: 160-174.

35. Polack

S,

Yorston

D, Lopez-Ramos

A, Lepe-Orta

S, Baia RM, Alves L,

GrauAlvidrez C,

Gomez-Bastar

P, KuperH. Rapid assessment

of avoidable blindness and diabetic retinopathy in Chiapas, Mexico. Ophthalmology 2012; 119: 1033-40. .

https://doi.Org/10.1016/j.ophtha.2011.11.002

36. Sabanayagam

C, Yip W, Ting DS, Tan G, Wong TY. Ten Emerging Trendsinthe Epidemiology of Diabetic Retinopathy. Ophthalmic Epidemiol 2016; 23: 209-22. https://doi.org/10.1080/09286586.2016.1193618

37. Scanlon

PH. The English National Screening Programme for diabetic retinopathy 2003-2016. Acta Diabetologica 2017; 54: 515-525.

https://doi.org/10.1007/s00592-017-0974-1

38. Schneider

M, Süveges

I.

Retinopathia

diabetica:

magyarországi

epidemiológiai adatok. Szemészet 2005; 141: 441-444.

39. Shi

L,

Wu H, Dong

J,

Jiang

K,

Lu

X,

Shi

J.

Telemedicine

for detecting diabetic retinopathy: a systematic review and meta-analysis. Br J Ophthalmol 2015; 99: 823-31. https://doi.org/10.1136/bjophthalmol-2014-305631

40. Somfai

G,

Ferencz

M,

Fiedler 0, Varga T, Somogyi A,

Németh J.

Diabé

teszes retinopathia

a

XXL század

elején: prevenció, diagnosztika és terápia. Magyar Belorvosi Archívum 2007; 60: 123-127.

41. Stefansson

E,

Bek T, Porta M, Larsen

N,

Kristinsson JK, Agardh E. Screening and

prevention of diabetic blindness. Acta Ophthalmol Scand 2000; 78: 374-85. doi: 10.1034/j.1600-0420.2000.078004374.x.

42. Stefansson

E.

Prevention of diabetic blindness. Br J Ophthalmol 2006;

90: 2-3. https://doi.org/10.1136/bjo.2005.082065

frag?